18677542

Source:http://linkedlifedata.com/resource/pubmed/id/18677542

Download in:

Switch to

Custom View

Named Graph Language Inference

Statements in which the resource exists as a subject.
Predicate	Object
rdf:type	pubmed:Citation
lifeskim:mentions	umls-concept:C0032854, umls-concept:C0038952, umls-concept:C0281361, umls-concept:C0524869, umls-concept:C0681842, umls-concept:C0728940, umls-concept:C1561558
pubmed:issue	10
pubmed:dateCreated	2008-9-22
pubmed:abstractText	American Joint Committee on Cancer (AJCC) staging for pancreatic adenocarcinoma is a validated predictor of prognosis but insufficiently discriminates postresection survival. We hypothesized that genetic analysis of resected cancers would correlate with tumor biology and postoperative survival.
pubmed:language	eng
pubmed:journal	http://linkedlifedata.com/resource/pubmed/journal/9706084
pubmed:citationSubset	IM
pubmed:chemical	http://linkedlifedata.com/resource/pubmed/chemical/KRAS protein, human, http://linkedlifedata.com/resource/pubmed/chemical/Proto-Oncogene Proteins, http://linkedlifedata.com/resource/pubmed/chemical/ras Proteins
pubmed:status	MEDLINE
pubmed:month	Oct
pubmed:issn	1873-4626
pubmed:author	pubmed-author:BartlettDavid LDL, pubmed-author:FrankoJanJ, pubmed-author:HughesSteven JSJ, pubmed-author:KrasinskasAlyssa MAM, pubmed-author:LeeKenneth K WKK, pubmed-author:MoserA JamesAJ, pubmed-author:NikiforovaMarina NMN, pubmed-author:ZarnescuNarcis ONO, pubmed-author:ZehHerbert JHJ3rd
pubmed:issnType	Electronic
pubmed:volume	12
pubmed:owner	NLM
pubmed:authorsComplete	Y
pubmed:pagination	1664-72; discussion 1672-3
pubmed:meshHeading	pubmed-meshheading:18677542-Adenocarcinoma, pubmed-meshheading:18677542-Aged, pubmed-meshheading:18677542-Aged, 80 and over, pubmed-meshheading:18677542-Ampulla of Vater, pubmed-meshheading:18677542-Carcinoma, Pancreatic Ductal, pubmed-meshheading:18677542-Common Bile Duct Neoplasms, pubmed-meshheading:18677542-Female, pubmed-meshheading:18677542-Genes, Tumor Suppressor, pubmed-meshheading:18677542-Humans, pubmed-meshheading:18677542-Loss of Heterozygosity, pubmed-meshheading:18677542-Male, pubmed-meshheading:18677542-Middle Aged, pubmed-meshheading:18677542-Mutation, pubmed-meshheading:18677542-Pancreatectomy, pubmed-meshheading:18677542-Pancreatic Neoplasms, pubmed-meshheading:18677542-Pilot Projects, pubmed-meshheading:18677542-Predictive Value of Tests, pubmed-meshheading:18677542-Prognosis, pubmed-meshheading:18677542-Proto-Oncogene Proteins, pubmed-meshheading:18677542-Retrospective Studies, pubmed-meshheading:18677542-Survival Analysis, pubmed-meshheading:18677542-ras Proteins
pubmed:year	2008
pubmed:articleTitle	Loss of heterozygosity predicts poor survival after resection of pancreatic adenocarcinoma.
pubmed:affiliation	UPMC Pancreatic Cancer Center, Division of Surgical Oncology, 497 Scaife Hall, 3550 Terrace Street, Pittsburgh, PA 15261, USA.
pubmed:publicationType	Journal Article, Research Support, Non-U.S. Gov't